Skip to content
ClinCalc Pro
Menu
Glucose Supplement

Dextrose 50% (Glucose 50%)

Brand names: Glucose 50% Injection

Dextrose 50% is a concentrated intravenous glucose solution used in the emergency treatment of severe symptomatic hypoglycaemia.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

It rapidly raises blood glucose by providing a directly usable carbohydrate substrate to the circulation and central nervous system.

Prescribing in practice

  • Highly hypertonic and irritant — give into a large or central vein and confirm patency, as extravasation can cause severe tissue necrosis.
  • Check capillary or laboratory glucose before and after administration and identify the cause of hypoglycaemia.
  • Use cautiously in suspected thiamine deficiency, where thiamine should be considered alongside or before glucose to reduce the risk of precipitating Wernicke's encephalopathy.

Monitoring

Monitor blood glucose closely after administration and recheck regularly until levels are stable.

Counselling the patient

  • Explain that this rapidly corrects a dangerously low blood sugar.
  • Advise the patient to eat a longer-acting carbohydrate once alert to prevent recurrence.
  • Tell the team to watch the cannula site for pain, swelling or leakage.

Evidence & guidelines

Intravenous glucose is the standard parenteral treatment for severe hypoglycaemia in patients unable to take oral carbohydrate.

Reference: JBDS Inpatient Hypoglycaemia Guidelines 2023; NICE CG100; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.

📚 MRCEM Revision

Featured in these MRCEM clinical pathways

Dextrose 50% (Glucose 50%) is a core drug in the following exam-focused workups on our sister siteReviseMRCEM.

MRCEM Primary / Intermediate / OSCE candidates: each pathway includes exam-style questions, RCEM/NICE citations, and FAQ summaries.